Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print October 31, 2007
DOI: 10.2337/db07-0837

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
db07-0837v1
57/2/444    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCrimmon, R. J.
Right arrow Articles by Sherwin, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCrimmon, R. J.
Right arrow Articles by Sherwin, R. S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Key role for AMP-activated Protein Kinase in the Ventromedial Hypothalamus in Regulating Counterregulatory Hormone Responses to Acute Hypoglycemia

Rory J. McCrimmon, Margaret Shaw, Xiaoning Fan, Haiying Cheng, Yuyan Ding, Monica C. Vella, Ligang Zhou, Ewan C. McNay, and Robert S. Sherwin

Yale University School of Medicine, Department of Internal Medicine and Endocrinology, New Haven, CT

Objective: To examine in vivo in a rodent model the potential role of AMP-activated protein kinase (AMPK) within the ventromedial hypothalamus in glucose-sensing during hypoglycemia.

Research Design and Methods: Using gene silencing technology to selectively down-regulate AMPK in the ventromedial hypothalamus (VMH), a key hypothalamic glucose-sensing region, we demonstrate a key role for AMPK in the detection of hypoglycemia. In vivo hyperinsulinemic hypoglycemic (50 mg dl-1) clamp studies were performed in awake, chronically catheterized Sprague-Dawley rats who had been microinjected bilaterally to the VMH with an adeno-associated viral vector (AAV) expressing a short hairpin RNA for AMPK{alpha} .

Results: In comparison to control studies, VMH AMPK down-regulation resulted in suppressed glucagon (~60%) and epinephrine (~40%) responses to acute hypoglycemia. Rats with VMH AMPK down-regulation also required more exogenous glucose to maintain the hypoglycemia plateau, and showed significant reductions in endogenous glucose production and whole body glucose uptake.

Conclusions: We conclude that AMPK in the VMH plays a key role in the detection of acute hypoglycemia and initiation of the glucose counterregulatory response.


Correspondence: rory.mccrimmon{at}yale.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
R. S. Sherwin
Bringing Light to the Dark Side of Insulin: A Journey Across the Blood-Brain Barrier
Diabetes, September 1, 2008; 57(9): 2259 - 2268.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.